美托洛尔治疗血液透析患者室性期前收缩的疗效观察

Observation on the efficacy of Metoprolol in premature ventricular beats of hemodialysis patients

目的观察美托洛尔治疗血液透析患者室性期前收缩的临床疗效。方法选取83例血液透析频发室性期前收缩患者,按心率快慢分为A、B两组,均给予美托洛尔治疗。结果美托洛尔可减少室性期前收缩的发生及缓解症状。A组疗效优于B组(P<0.05),总有效率A组(90.5%)也高于B组(73.2%)(P<0.05)。在治疗过程中未发现明显副作用。结论美托洛尔治疗血液透析患者室性期前收缩有效、安全。

Objective To observe the clinical efficacy of Metoprolol on the premature ventricular beats of hemodialysis patients. Methods Eighty-three hemodialysis patients with premature ventricular beats were chosen and divided into group A with fast heart rate and group B with slow heart rate. Both groups were given Metoprolol tablets. Results Metoprolol can reduce the occurrence of premature ventrieular beats and relieve symptoms. The total effective rate was 90. 5% in group A, while 73.2% in group B. The difference between them was statistical significance （P 〈 0. 05）. No adverse reactions were found during the process of treatment. Conclusion The treatment of Metoprolol tablet on premature ventrieular beats of hemodialysis patients is effective and safe.